월경전불쾌장애의 약물치료 3상 임상 연구 메타분석
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 염선경 | - |
dc.contributor.author | 유민지 | - |
dc.contributor.author | 박나윤 | - |
dc.contributor.author | 김성민 | - |
dc.contributor.author | 이경욱 | - |
dc.contributor.author | 박현태 | - |
dc.contributor.author | 신정호 | - |
dc.contributor.author | 허준용 | - |
dc.contributor.author | 김선행 | - |
dc.contributor.author | 김탁 | - |
dc.date.accessioned | 2021-09-07T01:46:28Z | - |
dc.date.available | 2021-09-07T01:46:28Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2012 | - |
dc.identifier.issn | 2287-8580 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/109898 | - |
dc.description.abstract | Premenstrual dysphoric disorder (PMDD) is a common condition that temporarily, but repetitively affects patient’s global function. Patients and physicians alike are often uncertain whether prescription medication for PMDD is suffi ciently effective. The primary objective of this analysis is signal detection in effi cacy of pharmacological treatments in PMDD. Secondary objective is to review which symptoms are likely to respond to which medications. The review included otherwise healthy women with clinician confi rmed diagnosis of PMDD who participated in phase 3 clinical trials for the treatment of PMDD. Twelve pair-wise comparisons of drug and placebo for 2,420 patients with PMDD were performed. Oral contraceptives and selective serotonin receptor inhibitor were effective in alleviating symptoms of PMDD compared to placebo. Both Intermittent and continuous administration were more effective than placebo. This meta-analysis provides a signal that pharmacological treatment of PMDD is effective | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | 대한산부인과학회 | - |
dc.title | 월경전불쾌장애의 약물치료 3상 임상 연구 메타분석 | - |
dc.title.alternative | PHARMACOTHERAPY FOR PREMENSTRUAL DYSPHORIC DISORDER: A META-ANALYSIS OF PHASE 3 TRIALS | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 이경욱 | - |
dc.contributor.affiliatedAuthor | 박현태 | - |
dc.contributor.affiliatedAuthor | 신정호 | - |
dc.identifier.bibliographicCitation | Obstetrics & Gynecology Science, v.55, no.03, pp.143 - 147 | - |
dc.relation.isPartOf | Obstetrics & Gynecology Science | - |
dc.citation.title | Obstetrics & Gynecology Science | - |
dc.citation.volume | 55 | - |
dc.citation.number | 03 | - |
dc.citation.startPage | 143 | - |
dc.citation.endPage | 147 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001642637 | - |
dc.description.journalClass | 2 | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Premenstrual syndrome | - |
dc.subject.keywordAuthor | Drug therapy | - |
dc.subject.keywordAuthor | Meta-analysis | - |
dc.subject.keywordAuthor | Clinical trial | - |
dc.subject.keywordAuthor | phase 3 | - |
dc.subject.keywordAuthor | 월경전불쾌장애 약물치료 | - |
dc.subject.keywordAuthor | 메타분석 | - |
dc.subject.keywordAuthor | 3상 임상 연구 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.